The Effect of Bitter Melon (Momordica charantia) Extract on the Uptake of Tc Labeled Paclitaxel: In Vitro Monitoring in Breast Cancer Cells.

Background: Bitter Melon Extract (BME) is widely used for the treatment of various diseases worldwide due to its rich phytochemical and antioxidant content. The well-known anti-cancer drug Paclitaxel (PAC) plays a major role in the treatment of various cancer types such as ovarian, breast, and lung cancer. Technetium-99m (99mTc) radiolabeled paclitaxel is emerging as an imaging probe for breast cancer in vivo.